Invicta Diagnostic IPO Details
The Invicta Diagnostic IPO is a book build issue with a total issue size of ₹28.12 cr Invicta Diagnostic IPO opened for subscription on Dec 01, 2025 and closed on Dec 03, 2025. Invicta Diagnostic IPO is set price band at ₹80 to ₹85 per share, with a lot size of 1600 shares. Minimum investment for Retail investors was ₹272,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Dec 04, 2025, and listed on the NSE on Dec 08, 2025.
Bigshare Services Pvt Ltd has been appointed as the registrar. Socradamus Capital Private Limited are the Book Running Lead Manager for the issue.
Before investing in the Invicta Diagnostic IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 80 – 85
- Lot Size
- 1600
- Issue Size
- ₹28.12 Cr
- Minimum Investment
- ₹272000 (3200 Shares)
- Listing Date
- 08 December 2025
Current GMP
₹3 (+3.53%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Invicta Diagnostic Limited
Incorporated in January 2021, Invicta Diagnostics Limited is a Mumbai-based diagnostic services provider offering comprehensive radiology and pathology solutions under its brand “PC Diagnostics.” The company operates through a hub-and-spoke model across the Mumbai Metropolitan Region, delivering accessible, high-quality diagnostic services.
Operational Footprint
Invicta Diagnostics manages 7 diagnostic centres and one central laboratory across Mumbai, comprising:
- Flagship Hub – Thane West:
Full-spectrum pathology services along with advanced radiology, including CT and MRI. - Three Additional Hubs – Bhayandar, Byculla, Marol:
Offering specialized diagnostic tests and imaging services. - Four Spoke Centres – Lower Parel, Sewri, Mazgaon, Kalwa:
Focused on basic imaging (X-ray, ultrasound) and sample collection.
Test Portfolio
Invicta Diagnostics provides an extensive range of tests, including:
- Pathology:
~60 routine tests and ~487 specialized tests. - Radiology:
~96 basic and ~130 advanced radiology tests.
Key Services
- Routine Pathology Tests:
CBC, lipid profile, liver function (LFT), kidney function (KFT), thyroid panels. - Specialized Pathology Tests:
Molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels. - Radiology Services:
X-ray, ultrasound, CT, MRI, and teleradiology services. - Sample Collection Network:
Home collection via trained phlebotomists and sample collection at spoke centres, ensuring wide patient reach.
Team Strength
As of May 31, 2025, the company’s workforce includes:
- 5 laboratory doctors
- 20 radiologists
- 127 trained technical staff
- 105 permanent employees in total
Invicta Diagnostic IPO Promoters
- Dr. Ketan Jayantilal Jain
- Dr. Sanket Vinod Jain
- Rohit Prakash Srivastava
- Badal Kailash Naredi
- Jayesh Prakash Jain
Promoters Holding
Holding Pre Issue
90.52%
Holding Post Issue
0.00%
Invicta Diagnostic IPO Objective
The Company Invicta Diagnostic IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra
- General Corporate purposes
Address / Contact Info
Invicta Diagnostic Ltd.
1 GF, Plot 217, Ambavat Bhavan
N.M Joshi Marg,Delisle Road
Mumbai, Maharashtra, 400013
Phone: 022 - 4971 0036
Email: investors@pcdiagnostics.in
Website: https://www.pcdiagnostics.in/
IPO Snapshot
Book Running Lead Managers
- Socradamus Capital Private Limited
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Invicta Diagnostic IPO is a Book-building IPO with a total issue size of ₹28.12 crore. The Invicta Diagnostic IPO price band is ₹80 to 85 per share. The Invicta Diagnostic IPO subscription opens on Mon, Dec 1, 2025, and closes on Wed, Dec 3, 2025. The Invicta Diagnostic IPO will be listed on the NSE. Bigshare Services Pvt Ltd is the registrar for the Invicta Diagnostic IPO.
The Invicta Diagnostic IPO opens on Mon, Dec 1, 2025 and closes on Wed, Dec 3, 2025
Invicta Diagnostic IPO Price Band is ₹80 to 85 per share.
Invicta Diagnostic IPO lot size is 1600 shares, Retail investors need a minimum investment of ₹272000 based on the upper price band
The minimum investment for Invicta Diagnostic IPO is ₹272000, based on one lot of 1600 shares at the upper price band of ₹85 per share.
Investors can apply for the Invicta Diagnostic IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Wed, Dec 3, 2025. The application amount remains blocked until the Invicta Diagnostic IPO allotment is finalized.
Invicta Diagnostic IPO issue size is ₹28.12 crores.
Invicta Diagnostic IPO allotment date is Wed, Jul 1, 2026.
The registrar for Invicta Diagnostic IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Invicta Diagnostic IPO allotment status, refund processing, and other IPO-related information.
The Invicta Diagnostic IPO GMP (Grey Market Premium) is ₹0 as of Mon, Dec 8, 2025. Based on the upper price band of ₹85 per share, the estimated Invicta Diagnostic IPO listing price is ₹85, indicating a potential listing gain of approximately 0% over the issue price.